Defiance Daily Target 2x Long MSTR ETF (MSTX) Covered Calls

Mast Therapeutics Inc is a biopharmaceutical company. The Company is engaged in developing novel therapies for serious or life-threatening diseases with unmet needs. Its pipeline includes MST-188 development programs in adjunctive thrombolytic therapy.

You can sell covered calls on Defiance Daily Target 2x Long MSTR ETF to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MSTX (prices last updated Fri 4:16 PM ET):

Defiance Daily Target 2x Long MSTR ETF (MSTX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
80.60 +14.73 78.50 78.80 14.0M - 0.0
Covered Calls For Defiance Daily Target 2x Long MSTR ETF (MSTX)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jan 17 81 14.10 64.70 21.8% 274%
Feb 21 81 24.00 54.80 43.8% 250%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. Its lead product MST-188 has cytoprotective and hemorheologic properties and inhibits inflammatory processes and thrombosis. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA.